38 related articles for article (PubMed ID: 8223839)
1. Pharmacokinetic and bioequivalent study of a generic Metoprolol tablet preparation.
Yuen KH; Peh KK; Chan KL; Toh WT
Drug Dev Ind Pharm; 1998 Oct; 24(10):955-9. PubMed ID: 9876550
[TBL] [Abstract][Full Text] [Related]
2. Clinical Pharmacokinetics of Metoprolol: A Systematic Review.
Zamir A; Hussain I; Ur Rehman A; Ashraf W; Imran I; Saeed H; Majeed A; Alqahtani F; Rasool MF
Clin Pharmacokinet; 2022 Aug; 61(8):1095-1114. PubMed ID: 35764772
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic variability of beta-adrenergic blocking agents used in cardiology.
Ågesen FN; Weeke PE; Tfelt-Hansen P; Tfelt-Hansen J;
Pharmacol Res Perspect; 2019 Aug; 7(4):e00496. PubMed ID: 31338197
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic Variability of Drugs Used for Prophylactic Treatment of Migraine.
Tfelt-Hansen P; Ågesen FN; Pavbro A; Tfelt-Hansen J
CNS Drugs; 2017 May; 31(5):389-403. PubMed ID: 28405886
[TBL] [Abstract][Full Text] [Related]
5. Are all beta-blockers the same for chronic heart failure?
Gottlieb SS
Curr Cardiol Rep; 2001 Mar; 3(2):124-9. PubMed ID: 11177669
[TBL] [Abstract][Full Text] [Related]
6. Approaches to meeting the criteria for fixed dose antihypertensive combinations. Focus on metoprolol.
Kendall MJ
Drugs; 1995 Sep; 50(3):454-64. PubMed ID: 8521768
[TBL] [Abstract][Full Text] [Related]
7. Controlled release metoprolol formulations. A review of their pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and ischaemic heart disease.
Plosker GL; Clissold SP
Drugs; 1992 Mar; 43(3):382-414. PubMed ID: 1374320
[TBL] [Abstract][Full Text] [Related]
8. Metoprolol succinate extended release/hydrochlorothiazide combination tablets.
Hainer JW; Sugg J
Vasc Health Risk Manag; 2007; 3(3):279-88. PubMed ID: 17703635
[TBL] [Abstract][Full Text] [Related]
9. The pharmacokinetics and pharmacodynamics of metoprolol after conventional and controlled-release administration in combination with hydrochlorothiazide in healthy volunteers.
Lundborg P; Abrahamsson B; Wieselgren I; Walter M
Eur J Clin Pharmacol; 1993; 45(2):161-3. PubMed ID: 8223839
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic and pharmacodynamic comparison of metoprolol CR/ZOK once daily with conventional tablets once daily and in divided doses.
Lücker P; Moore G; Wieselgren I; Olofsson B; Bergstrand R
J Clin Pharmacol; 1990 Feb; 30(S2):S17-27. PubMed ID: 2312775
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic and pharmacodynamic evaluation of metoprolol controlled release (CR/ZOK) 50 mg in young subjects.
Wieselgren I; Lundborg P; Sandberg A; Olofsson B; Bergstrand R
J Clin Pharmacol; 1990 Feb; 30(S2):S28-32. PubMed ID: 2312776
[TBL] [Abstract][Full Text] [Related]
12. The effect of food on the relative bioavailability of rapidly dissolving immediate-release solid oral products containing highly soluble drugs.
Yu LX; Straughn AB; Faustino PJ; Yang Y; Parekh A; Ciavarella AB; Asafu-Adjaye E; Mehta MU; Conner DP; Lesko LJ; Hussain AS
Mol Pharm; 2004; 1(5):357-62. PubMed ID: 16026005
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and pharmacodynamics of controlled-release metoprolol: a comparison with atenolol.
Blomqvist I; Westergren G; Sandberg A; Jonsson UE; Lundborg P
Eur J Clin Pharmacol; 1988; 33 Suppl():S19-24. PubMed ID: 3371390
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic and pharmacodynamic properties of a new controlled-release formulation of metoprolol: a comparison with conventional tablets.
Sandberg A; Blomqvist I; Jonsson UE; Lundborg P
Eur J Clin Pharmacol; 1988; 33 Suppl():S9-14. PubMed ID: 3371395
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
